Table of contents as filed with the Securities and Exchange Commission on April 8, 2016 Registration No. 333-210291

Yüklə 6,05 Mb.

səhifə	73/81
tarix	02.08.2018
ölçüsü	6,05 Mb.
	#66317

1 ... 69 70 71 72 73 74 75 76 ... 81

F-52

TABLE OF CONTENTS

The Chemours Company

Notes to the Consolidated Financial Statements
(Dollars in millions, except per share)

Condensed Consolidating Statements of Comprehensive Income

	Year Ended December 31, 2014
	Parent Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations and Adjustments			Consolidated
Net sales		$	—		$	4,593		$	3,722		$	(1,883 )		$	6,432
Cost of goods sold			—			3,863			3,093			(1,884 )			5,072
Gross profit			—			730			629			1			1,360
Selling, general and administrative expense			—			429			256			—			685
Research and development expense			—			127			16			—			143
Employee separation and asset related charges, net			—			11			10			—			21
Total expenses			—			567			282			—			849
Equity in earnings of affiliates			—			—			20			—			20
Equity in earnings of subsidiaries			400			—			—			(400 )			—
Other income (expense), net			—			80			(61 )			—			19
Income before income taxes			400			243			306			(399 )			550
Provision for income taxes			—			75			76			(2 )			149
Net income			400			168			230			(397 )			401
Less: Net income attributable to noncontrolling interests			—			—			1			—			1
Net income attributable to Chemours		$	400		$	168		$	229		$	(397 )		$	400
Comprehensive income attributable to Chemours		$	400		$	168		$	229		$	(397 )		$	400

Yüklə 6,05 Mb.

Dostları ilə paylaş:

1 ... 69 70 71 72 73 74 75 76 ... 81

Table of contents as filed with the Securities and Exchange Commission on April 8, 2016 Registration No. 333-210291​

Table of contents as filed with the Securities and Exchange Commission on April 8, 2016 Registration No. 333-210291